UK markets open in 5 hours 24 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,543.30 +336.17 (+1.85%) CRUDE OIL
79.23 +0.28 (+0.35%) GOLD FUTURES
2,311.90 +2.30 (+0.10%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,375.06 +1,795.70 (+3.94%)
RELMADA THERAPEUT.DL-,001 (4E2.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:04AM CEST
| Previous close | 3.2400 |
| Open | 3.4000 |
| Bid | 3.4400 x N/A |
| Ask | 3.5000 x N/A |
| Day's range | 3.4000 - 3.4000 |
| 52-week range | 3.4000 - 3.4000 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript March 19, 2024 Relmada Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.84, expectations were $-0.88. RLMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and […]
- Thomson Reuters StreetEvents
Q4 2023 Relmada Therapeutics Inc Earnings Call
Q4 2023 Relmada Therapeutics Inc Earnings Call
- GuruFocus.com
Relmada Therapeutics Inc Reports Full-Year and Q4 2023 Financial Results
Progress in CNS Treatments Amid Financial Challenges
© 2024 Yahoo. All rights reserved.